Impact of bolus dosing versus continuous infusion of piperacillin and tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
TW Felton, J Goodwin, L O'Connor… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Management of nosocomial pneumonia is frequently complicated by bacterial resistance.
Extended infusions of beta-lactams are increasingly being used to improve clinical …
Extended infusions of beta-lactams are increasingly being used to improve clinical …
[PDF][PDF] Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas …
TW Felton, J Goodwin, L O'Connor, A Sharp… - 2013 - Citeseer
MATERIALS AND METHODS Antimicrobial agent. For the HFIM, the clinical formulation of
piperacillin-tazobactam (2 g/0.25 g) was used and was supplied by Stragen UK (Surrey …
piperacillin-tazobactam (2 g/0.25 g) was used and was supplied by Stragen UK (Surrey …
[引用][C] Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas …
TW FELTON, J GOODWIN… - Antimicrobial …, 2013 - pascal-francis.inist.fr
Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the
Development of Antimicrobial Resistance in Pseudomonas aeruginosa CNRS Inist Pascal-Francis …
Development of Antimicrobial Resistance in Pseudomonas aeruginosa CNRS Inist Pascal-Francis …
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
TW Felton, J Goodwin, L O'Connor… - Antimicrobial …, 2013 - research.manchester.ac.uk
Management of nosocomial pneumonia is frequently complicated by bacterial resistance.
Extended infusions of beta-lactams are increasingly being used to improve clinical …
Extended infusions of beta-lactams are increasingly being used to improve clinical …
[PDF][PDF] Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas …
TW Felton, J Goodwin, L O'Connor, A Sharp… - 2013 - researchgate.net
MATERIALS AND METHODS Antimicrobial agent. For the HFIM, the clinical formulation of
piperacillin-tazobactam (2 g/0.25 g) was used and was supplied by Stragen UK (Surrey …
piperacillin-tazobactam (2 g/0.25 g) was used and was supplied by Stragen UK (Surrey …
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
TW Felton, J Goodwin, L O'Connor… - Antimicrobial …, 2013 - pubmed.ncbi.nlm.nih.gov
Management of nosocomial pneumonia is frequently complicated by bacterial resistance.
Extended infusions of beta-lactams are increasingly being used to improve clinical …
Extended infusions of beta-lactams are increasingly being used to improve clinical …
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.
TW Felton, J Goodwin, L O'Connor, A Sharp… - Antimicrobial Agents …, 2013 - europepmc.org
Management of nosocomial pneumonia is frequently complicated by bacterial resistance.
Extended infusions of beta-lactams are increasingly being used to improve clinical …
Extended infusions of beta-lactams are increasingly being used to improve clinical …
[PDF][PDF] Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas …
TW Felton, J Goodwin, L O'Connor, A Sharp… - 2013 - scienceopen.com
MATERIALS AND METHODS Antimicrobial agent. For the HFIM, the clinical formulation of
piperacillin-tazobactam (2 g/0.25 g) was used and was supplied by Stragen UK (Surrey …
piperacillin-tazobactam (2 g/0.25 g) was used and was supplied by Stragen UK (Surrey …
Impact of bolus dosing versus continuous infusion of piperacillin and tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.
TW Felton, J Goodwin, L O'Connor, A Sharp, L Gregson… - 2013 - cabidigitallibrary.org
Management of nosocomial pneumonia is frequently complicated by bacterial resistance.
Extended infusions of beta-lactams are increasingly being used to improve clinical …
Extended infusions of beta-lactams are increasingly being used to improve clinical …
[HTML][HTML] Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas …
TW Felton, J Goodwin, L O'Connor… - Antimicrobial Agents …, 2013 - ncbi.nlm.nih.gov
Management of nosocomial pneumonia is frequently complicated by bacterial resistance.
Extended infusions of beta-lactams are increasingly being used to improve clinical …
Extended infusions of beta-lactams are increasingly being used to improve clinical …